Administrator ITI

Administrator ITI

BIOMODEX, a Paris-based medical device company, announced it has received an additional $15 million in Series A funding led by European investment firms Idinvest Partners and InnovAllianz. With the participation of pre-existing investors, LBO France and Inserm Transfert Initiative, BIOMODEX’s total financing is now more the $18.5 million.